期刊文献+

HO-1基因表达对伊马替尼耐药的慢性髓系白血病细胞增殖的影响 被引量:3

Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells
原文传递
导出
摘要 目的通过氯高血红素(Heroin)诱导伊马替尼耐药慢性髓系白血病(CML)细胞株K562/A02.IM中血红素加氧酶-1(HO-1)基因表达,探讨HO-1基因对伊马替尼耐药CML细胞增殖的影响,为治疗CML多药耐药及新药的开发提供思路和实验依据。方法采用RT—PCR法检测20例CML伊马替尼耐药患者骨髓细胞中HO-1基因的表达,半定量RT—PCR法和Westernblot法分别检测不同剂量Hemin处理K562/A02-IM细胞不同时间后HO-1的表达,通过AnnexinV/H双染色法检测细胞凋亡情况,采用MTT法检测Hemin诱导及锌原卟啉抑制HO-1表达与细胞存活率的关系。结果RT—PCR结果显示耐药患者骨髓细胞中HO-1基因阳性表达,半定量RT—PCR和Westernblot法显示,不同浓度的Heroin(0、10、20及40μmol/L)处理K562/AO2-IM细胞16h后,HO-1的表达量随Heroin浓度的升高而增加,存在剂量依赖关系,而20μmol/LHeroin分别处理K562/AO2-IM细胞0、8、16、24h后,HO-1的表达量在处理16h组最高。AnnexinV/PI法检测显示,0、10、20及40pmlol/LHemin作用于K562/AO2-IM细胞16h后细胞凋亡率分别为(17.61±0.01)%、(12.13±0.11)%、(7.94±0.03)%和(4.62±0.15)%,其抗凋亡的作用呈剂量依赖性;20pmol/LHemin作用K562/A02-IM细胞8、16及24h的细胞凋亡率分别为(14.72±0.05)%、(8.15±0.07)%和(16.37±0.13)%。MTT法检测显示与对照组相比,Hemin诱导K562/AO2-IM细胞HO-1基因表达促进了细胞的增殖,且作用存在剂量依赖关系;而锌原卟啉抑制HO-1的表达,促进了细胞的凋亡(P〈0.05)。结论CML伊马替尼耐药患者骨髓细胞HO-1基因阳性表达,HO-1是一种可诱导表达型基因,具有抗细胞凋亡及促进细胞增殖的作用,抑制HO-1表达可能成为治疗CML耐药的新方法。 Objective To investigate the effect of heine oxygenase-1 ( HO-1 ) expression on cell growth and apoptosis in imatinib resistant chronic myeloid leukemia (CML) cells (K562/A02-IM) , and explore the relationship between HO-1 gene and CML. Methods The expression of HO-1 in 20 drug-resistant CML patients was detected by RT-PCR. Different concentrations of heroin were used to induce HO-1 expres- sion of K562/A02-IM, HO-1 expression at different time was detected by RT-PCR and Western blot analysis. Cell apoptosis was detected by Annexin V/PI staining, and MTT assay was used to detect viability of K562/ A02-1M cells after induction or inhibition of HO-1 gene by heroin and zinc protoporphyrin (ZPP). Results RT-PCR showed that HO-1 was expressed in the bone marrow mononuclear cells (BMMNCs). When treated with heroin at different concentrations (0, 10, 20, 40 μmol/L) for 16 h, the expression of HO-1 in K562/ AO2-IM was increased in a dose-dependent manner, and peaked at 20 μmot/L of hemin for 16 h. The apoptosis rates were (17.61 ±0.01)% , (12.13±0.11)% , (7.94 ±0.03)% and (4.62±0.15)% at 0,10, 20 and40 Ixmol/L of hemin respectively for 16 h and were (14.7±0.05)% , (8. 1±0.07)% and (16.3 ± 0.13)% at 20μmol/L of hemin treatment for 8,16, and 24 h respectively. Hemin induced apoptosis of K562/AO2-IM cells in a dose-dependent manner. The expression of HO-I was induced in K562/AO2-IM cells in a dose-dependent manner, and the survival of K562/AO2-IM cells was significantly increased as compared to that of control group. When HO-1 was inhibited by ZPP, the ceils survival was sharply decreased compared to that of the control group (P 〈0.05). Conclusion HO-1 was expressed in the BMMNCs. It is a kind of molecules whose expression can be induced and can promote the growth of drug-resistant cells. Inhibition of HO-1 expression probably be used for the treatment of drug-resistant CML.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2011年第6期388-391,共4页 Chinese Journal of Hematology
基金 国家自然科学基金(30760276、30460127、81070444) 贵州省科技基础平台专项资金(黔科平台[2009]4007)
关键词 血红素加氧酶-1 氯高血红素 伊马替尼耐药 K562/AO2-IM细胞 细胞凋亡 Heine oxygenase-1 Hemin Imatinib resistant K562/A02-IM cells Cell apoptosis
  • 相关文献

参考文献11

  • 1Jozkowicz A, Was H, Dulak J. Heine oxygenase-1 in tumors:is it a false friend? Antioxid Redox Signal, 2007,9: 2099-2117.
  • 2Taha H, Skrzypek K, Guevara I, et al. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic vari- ants. Arterioscler Thromb Vasc Biol,2010,30 : 1634-1641.
  • 3Dezoti C, Watanabe M, Ferreira-Pinto C, et al. Functional pro- tection of heme-oxygenase-1 enzyme in ischemic and toxic acute kidney injury. Acta Paul Enferm, 2009,22:490-493.
  • 4Fang J, Akaike T, Maeda H. Antiapoptotie role of heine oxygen- ase (HO) and the potential of HO as a target in anticancer treat- ment. Apoptosis, 2004,9: 27-35.
  • 5Was H, Ciehon T, Smolarezyk R, et al. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and via- bility of tumor cells, decreased survival of mice. Am J Pathol, 2006,169:2181-2198.
  • 6Lim IK. TIS21 (/BTG/PC3) as a link between ageing and canc- er: cell cycle regulator arid endogenous cell death molecule. J Cancer Res Clin Oncol,2006,132:417426.
  • 7Kumar D, Bhaskaran M, Alagappan L, et al. Heine oxygenase-1 modulates mesangial cell proliferation by p21Waf1 upregulation. Ren Fail, 2010, 32: 254-258.
  • 8Wang X, Wang Y, Kim HP, et al. Carbon monoxide protects against hypcroxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem, 2007, 282: 1718-1726.
  • 9Berberat PO, Damhrauskas Z, Gulbinas A, et al. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res, 2005, 11: 3790- 3798.
  • 10Li Volti G, Wang J, Toaganos F, et al. Differential effect of heme oxygenase-1 in endothelial and smooth muscle cell cycle progression. Biochem Biophys Res Commun, 2002, 296:1077- 1082.

同被引文献13

  • 1Santos FP, Quintas-Cardama A. New drugs for chronic myeloge- nous leukemia. Curt Hematol Malig Rep, 2011, 6:96-103.
  • 2Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of ' real-time' quantitative reverse tran- scriptase polymerase chain reaction of fusion gene transcripts for re- sidual disease detection in leukemia a Europe Against Cancer program. Leukemia, 2003, 17:2318-2357.
  • 3Iacobucci I, Lonetti A, Messa F, et al, Expression of spliced on- cogenic Ikaros isoforms in Philadelphia-positive acute lymphoblas- tic leukemia patients treated with tyrosine kinase inhibitors: impli- cations for a new mechanism of resistance. Blood, 2008, 112: 3847-3855.
  • 4Mahon FX, Belloc F, Lagarde V, et al. MDR1 gene overexpres- sion confers resistance to imatinib mesylate in leukemia cell line models. Blood, 2003, 101:2368-2373.
  • 5Daley GQ. Dodging the magic bullet: understanding imatinib re- sistance. Cancer Biol Ther, 2003, 2 : 109-110.
  • 6Vasconcelos FC, Silva KL, Souza PS, et al. Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients. Cytometry B Clin Cytom, 2011, 80 : 158-166.
  • 7Kim TM, Ha SA, Kim HK, et al. Gene expression signatures as- sociated with the in vitro resistance to two tyrosine kinase inhibi- tors, nilotinib and imatinib. Blood Cancer J, 2011, 1 :e32.
  • 8Wang J, Chen Z, Xia X, et al. Improvement of combination chemotherapy tolerance by introduction of polycistronic retroviral vector drug resistance genes MGMT and MDR1 into human um- bilical cord blood CD34 + ceils. Leuk Res, 2002, 26:281-288.
  • 9Mayerhofer M, Florian S, Krauth MT, et al. Identification of heme oxygenase-1 as a novel BCR./ABL-depcndent survival factor in chronic mycloid leukemia. Cancer Res, 2004, 64: 3148- 3154.
  • 10WEI XiaoLi NI Hong WANG QingShan XIANG Rong WANG Yue.Impact of STAT4 gene silencing on the expression profile of proteins in EL-4 cells[J].Chinese Science Bulletin,2009,54(18):3265-3270. 被引量:4

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部